期刊文献+

甲睾酮联合米非司酮治疗高龄子宫肌瘤患者的疗效分析 被引量:2

Analysis of Therapeutic Effect of Methyltestosterone and Mifepristone Treatment of Elderly Patients with Myoma of Uterus
下载PDF
导出
摘要 目的:研究甲睾酮联合米非司酮治疗高龄子宫肌瘤患者的疗效。方法:本次研究选择2013年9月-2014年11月在笔者所在医院接受治疗的高龄子宫肌瘤患者70例。按入院先后顺序,将患者分为观察组和对照组各35例。对照组口服米非司酮治疗,观察组在此基础上服用甲睾酮治疗,治疗2个疗程,每疗程3个月,比较两组患者的治疗效果。结果:两组患者治疗后的子宫体积和肌瘤的体积均小于治疗前,差异均有统计学的意义(P<0.05),表示两组都可以缩瘤;且观察组患者的子宫体积及肌瘤体积均明显小于对照组,差异均有统计学的意义(P<0.05)。且观察组患者的治疗有效率为97.1%,明显高于对照组患者的80.0%,差异有统计学意义(P<0.05)。结论:甲睾酮和米非司酮联合治疗高龄子宫肌瘤患者能起到很好效果,可以帮助子宫肌瘤缩小,改善患者的症状。 Objective: To study the efficacy of mifepristone combined with methyltestosterone elderly patients with uterine fibroids.Method: 70 eases of elderly patients with uterine fibroids were selected in our hospital from September 2013 to November 2014.According to the order of admission, patients were divided into the observation group and the control group, 35 cases in each group.The control group was treated with mifepristone treatment, observation group was taken a testosterone treatment on this basis, two courses, each course of three months, the therapeutic effect of two groups were compared.Result: After treatment, two groups of patients'uterine fibroid volume and uterine volume were less than before, the differences were significant, with statistical significance(P〈0.05), saidthat both groups can shrink tumors ; uterine volume and range of patients in the observation group fibroid volume were lower than in the control group of patients, the differences were statistically significance(P〈0.05).And the effective treatment of patients in the observation group was 97.1%, significantly higher than 80.0% of the patients treatment efficiency, the differences were statistically significant(P〈0.05).Conelusion: Methyhestosterone and mifepristone treatment of elderly patients with uterine fibroids can take a good effect, can help shrink fibroids and improve the patient's symptoms.
作者 陈志刚
出处 《中外医学研究》 2015年第23期58-59,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 甲睾酮 米非司酮 高龄 子宫肌瘤 Methyhestosterone Mifepristone Elderly Uterine fibroids
  • 相关文献

参考文献5

二级参考文献61

  • 1陈传新.米非司酮与桂枝茯苓胶囊治疗子宫肌瘤的临床疗效分析[J].泰山医学院学报,2009,30(3):209-210. 被引量:16
  • 2张占海,林玉萍,徐海兰.软坚散结法配合自凝刀介入治疗子宫肌瘤临床观察[J].中医药学报,2004,32(4):43-43. 被引量:6
  • 3郑淑蓉.米非司酮用于妇科疾病的治疗[J].实用妇产科杂志,2006,22(2):72-74. 被引量:46
  • 4连利娟,林巧稚,妇科肿瘤学[M].第3版.北京:人民卫生出版社,2000.209,294.
  • 5Bozzini N, Rodrigues C J, Petti DA, et al. Effects of treatment with gonadotropin releasing hormone agonist on the uterine leiomyoma- ta structure [ J ]. Acta Obstet Gynecol Scand, 2003,82: 330- 334.
  • 6Sankaran S, Manyonda IT. Medical management of fibroids [ J ]. Best Pract Res Clin Obstet Gynaecol,2008,22 (4) :655-4576.
  • 7Scialli AR, Jestila KJ. Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri [ J ]. Fertil Steril, 1995,64:313-320.
  • 8Palomba S, Affinito P,Tommaselli GA, et al. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hor- mone analogues for the treatment of uterine leiomyomata [ J ]. Fertil Steril, 1998,70 : 111-118.
  • 9Palomba S, Russo T, Orio F, et al. Effectiveness of combined Gn- RH analogue plus raloxifene administration in the treatment of u- terine leiomyomas: a prospective, randomized, single-blind, pla- cebo-controlled clinical trial [ J ]. Hum Reprod, 2002,17 : 3213- 3219.
  • 10Friedman A J, Barbieri RL, Doubilet PM, et al. A randomized double-blind trial of a gonadotropin releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri [ J ]. Fertil Steril, 1988,49 : 404- 409.

共引文献264

同被引文献27

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部